Skip to content

High-Intensity Training Following Lung Transplantation

High-Intensity Training Following Lung Transplantation: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03155074
Acronym
HILT
Enrollment
54
Registered
2017-05-16
Start date
2017-08-22
Completion date
2019-01-31
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise Training, Lung Transplant

Brief summary

The HILT study is a prospective, single-blinded, randomized controlled trial comparing a high-intensity exercise training intervention with usual care among adult lung transplant recipients. Patients randomized to the training intervention arm will undergo individually tailored high-intensity exercise training (80-95% of maximum heart rate) three hours per week for 20 weeks. Training will be conducted at local fitness centers on a one-on-one basis.

Interventions

The exercise program will include a cardiovascular warm-up, high intensity interval training and progressive resistance training (PRT). The intervention will focus on high-intensity training, mainly by uphill walking on a treadmill at 80-95 % of the maximal heart rate and PRT in three series at 6-12 RM by leg press, chest press, back extension, seat row, and front raises. During the first four weeks, the patients will be introduced to the program while focusing on safety, techniques and familiarization. The endurance intensity and strength load will then continuously increase based on the patients' improvement, tolerance of dyspnea, and feelings of well-being or fatigue on each exercise day.

Sponsors

Norwegian School of Sport Sciences
CollaboratorOTHER
Oslo University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Stable medical condition in the opinion of the enrolling investigator * Able and willing to give informed consent

Exclusion criteria

* Expected survival less than 12 months * Unable to complete a maximal exercise test on a treadmill until exhaustion * Language barrier that interferes with data collection

Design outcomes

Primary

MeasureTime frameDescription
Change in peak oxygen uptake0-20 weeksMeasured by cardiopulmonary exercise test

Secondary

MeasureTime frameDescription
Change in forced expiratory volume in one second (FEV1)0-20 weeksMeasured by spirometry
Change submaximal exercise capacity0-20 weeksMeasured by 6-minute walk distance
Change in leg strength0-20 weeksMeasured by maximum leg press
Change in total body composition (fat, muscle and bone mass)0-20 weeksMeasured by dual-energy x-ray absorptiometry (DEXA)
Change in hand strength0-20 weeksMeasured by grip strength dynamometer
Change in health-related quality of life0-20 weeksMeasured by Short Form 36 (SF-36)
Change in upper body strength0-20 weeksMeasured by maximum breast press

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026